Why Using Artificial Intelligence in Clinical Trials is Becoming the New Normalby@itrex
914 reads

Why Using Artificial Intelligence in Clinical Trials is Becoming the New Normal

August 12th 2022
11 min
by @itrex 914 reads
tldt arrow
Read on Terminal Reader🖨️

Too Long; Didn't Read

The global AI-based clinical trials solution provider market is on the rise. It was valued at $1.3 billion in 2021 and is forecast to grow at a CAGR of 22% from 2022 to 2030.

Companies Mentioned

Mention Thumbnail
Mention Thumbnail

Coin Mentioned

Mention Thumbnail
featured image - Why Using Artificial Intelligence in Clinical Trials is Becoming the New Normal
ITRex HackerNoon profile picture

@itrex

ITRex

About @itrex
LEARN MORE ABOUT @ITREX'S EXPERTISE AND PLACE ON THE INTERNET.
react to story with heart
ITRex HackerNoon profile picture
by ITRex @itrex.Emerging Tech Development & Consulting: Artificial Intelligence. Advanced Analytics. Machine Learning. Big Data. Cloud
Bring us your challenge!

RELATED STORIES

L O A D I N G
. . . comments & more!
Hackernoon hq - po box 2206, edwards, colorado 81632, usa